Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021

Serum samples were collected pre- and post-booster vaccination with Comirnaty in 626 participants (aged ≥ 50 years) who had received two Comirnaty doses < 30 days apart, two Comirnaty doses ≥ 30 days apart or two Vaxzevria doses ≥ 30 days apart. Irrespective of primary vaccine type or schedule, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ireland, Georgina, Whitaker, Heather, Ladhani, Shamez N, Baawuah, Frances, Subbarao, Sathyvani, Linley, Ezra, Warrener, Lenesha, O’Brien, Michelle, Whillock, Corinne, Martin, Oliver, Moss, Paul, Ramsay, Mary E, Amirthalingam, Gayatri, Brown, Kevin E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739342/
https://www.ncbi.nlm.nih.gov/pubmed/34991777
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739342/
https://www.ncbi.nlm.nih.gov/pubmed/34991777
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.1.2101114

Ejemplares similares